NOMD Nomad Foods Ltd IFRS
Food and Kindred Products · NYSE · SEC CIK 1651717 · Reporting currency EUR · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 · EUR | FY20242024-12-31 · EUR | FY20232023-12-31 · EUR | FY20222022-12-31 · EUR | FY20212021-12-31 · EUR |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 3.03B | 3.10B | 3.04B | 2.94B | 2.61B |
| Cost of revenue | 2.21B | 2.18B | 2.19B | 2.12B | 1.86B |
| Gross profit | 823.00M | 917.80M | 858.70M | 815.30M | 744.30M |
| R&D expense | 23.30M | 20.90M | 20.90M | 19.30M | 19.20M |
| Operating income | 325.40M | 387.00M | 340.40M | 375.40M | 342.70M |
| Interest expense | 196.30M | 139.20M | 109.60M | 66.50M | 106.10M |
| Pretax income | 145.30M | 277.90M | 253.60M | 321.00M | 236.70M |
| Income tax | 8.60M | 50.80M | 60.90M | 71.20M | 55.70M |
| Net income | 136.70M | 227.10M | 192.70M | 249.80M | 181.00M |
| EBITDA | 434.80M | 483.90M | 435.40M | 464.00M | 414.30M |
| EPS (basic) | 0.91 | 1.41 | 1.13 | 1.43 | 1.02 |
| EPS (diluted) | 0.91 | 1.40 | 1.13 | 1.43 | 1.02 |
| Dividends declared per share | — | — | — | 25.21USD | 25.21USD |
| Balance sheet | |||||
| Cash & equivalents | — | — | — | 369.40M | 254.00M |
| Short-term investments | — | — | 0 | — | 0 |
| Receivables | 350.80M | 334.60M | 263.40M | 261.70M | 234.60M |
| Inventory | 440.60M | 441.50M | 446.40M | 457.10M | 410.60M |
| Current assets | 1.15B | 1.23B | 1.17B | 1.12B | 929.10M |
| PP&E, netmay include right-of-use assets (IFRS) | 527.70M | 518.60M | 501.60M | 493.90M | 489.20M |
| Goodwill | 2.10B | 2.11B | 2.10B | 2.10B | 2.10B |
| Intangibles | 2.46B | 2.47B | 2.47B | 2.46B | 2.46B |
| Total assets | 6.33B | 6.43B | 6.42B | 6.33B | 6.17B |
| Current liabilities | 1.07B | 1.12B | 1.03B | 940.80M | 966.20M |
| Short-term debt | 32.60M | 26.00M | 21.40M | 22.60M | 29.10M |
| Long-term debt | 2.26B | 2.15B | 2.11B | 2.14B | 2.20B |
| Total debt | 2.29B | 2.18B | 2.14B | 2.16B | 2.23B |
| Total liabilities | 3.84B | 3.77B | 3.82B | 3.72B | 3.87B |
| Shareholders' equity | 2.50B | 2.66B | 2.59B | 2.61B | 2.30B |
| Net debt | — | — | — | 1.80B | 1.97B |
| Cash flow statement | |||||
| Operating cash flow | 330.70M | 435.40M | 430.80M | 303.80M | 306.30M |
| Capital expenditure | 78.50M | 80.30M | 82.40M | 79.10M | 79.20M |
| Free cash flow | 252.20M | 355.10M | 348.40M | 224.70M | 227.10M |
| Investing cash flow | -74.60M | -64.40M | -76.80M | -78.70M | -660.00M |
| Financing cash flow | -332.10M | -366.40M | -321.50M | -108.10M | 214.40M |
| Depreciation & amortization | 109.40M | 96.90M | 95.00M | 88.60M | 71.60M |
| Stock-based compensation | 8.40M | 8.80M | 24.10M | 8.10M | 5.10M |
| Dividends paid | 91.30M | 89.20M | 0 | 0 | — |
| Share buybacks | 195.60M | 118.70M | 170.90M | 26.80M | 77.60M |
Free plan shows the latest 5 periods; Pro shows all 12 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.